DOCTORS INFO WEB
The website is open to all
Men's Health Topics
and Symptomatic Prostate Cancer
- Keyhole Surgery for Prostate Cancer
- Treating Fast Growing Prostate Cancers
- Prostate Cancer Explained
- Prostate Cancer Exam: What's the Controversy About?
- Hormonal Therapy for Prostate Cancer
- Bone Complications in Prostate Cancer
- Cancer and Cancer Treatment: Can it Affect Sleep?
Celebrex Plus Lipitor Could Fight Prostate Cancer
Combining painkiller with statin slows tumor progression,
mouse study suggests
April 14, 2008 (HealthDay News) -- Two widely used drugs -- one lowers
cholesterol and one is an anti-inflammatory -- may be useful in
controlling prostate cancer. New research being presented at the
American Association for Cancer Research annual meeting in San Diego finds
that the painkiller Celebrex and the statin Lipitor, when used together or
alone, can stop early prostate cancer before it becomes deadly. The
study was conducted in mice so the idea isn't yet ready for clinical use,
but experts said these preliminary results did look promising."
MRI Can Be
Predictor of Post-Treatment Prostate Cancer Spread
Those having radiation
therapy may want to request more aggressive therapy, study finds
study was published in the April issue of the journal Radiology.)
March 25, 2008 (HealthDay News) -- Magnetic resonance imaging (MRI) can
help predict the risk of cancer recurrence in prostate cancer patients who
are about to have radiation therapy, a new U.S. study says. (In
2008, it's estimated that more than 186,320 new cases of prostate cancer -
mostly in men over age 65 - will be diagnosed in the United States,
according to the National Cancer Institute. When prostate cancer is
diagnosed and treated early, the five-year survival rate is almost 100
percent. But the survival rate drops significantly once cancer spreads or
recurs beyond the prostate.)"
Predicts Prostate Cancer Prognosis
"The study determined that the
presence and degree of extracapsular extension -- the spread of cancer
beyond the membrane that surrounds the prostate gland -- seen on the
pre-treatment MR images was an important predictor of the cancer recurring
and spreading after the treatment. Specifically, results show patients
with extracapsular extension greater than five millimeters -- about the
diameter of a pencil eraser -- were more likely to have the cancer come
back and spread." Radiology, 2008;247
What's New |
Interventional Radiologist |
not recommend any particular physician listed on the site. The Doctors
listed on the site provided the information on the website, and
doctorsinfoweb.com did NOT review it for accuracy. The Directory
information is to help people start their search for a doctor, but it is up to
each of our visitors to research the medical background of a doctor.
Individual articles are based upon the opinions of the respective authors, who
own the copyright to the information they present.
Doctorsinfoweb.com does not endorse any linked organizations, products, and/or
services that the physicians may offer. Moreover, we do not control or guarantee
the currency, accuracy, relevance, or completeness of information found on its
own or linked, external Web sites.
Legal Disclaimer: The material presented on
doctorsinfoweb.com (Hope For Fibroids Inc.) web site is for informational
purposes only. It is not meant to be a substitute for physician care.
If you need medical advice on medical conditions you should discuss
them with a physician.
Saturday August 01, 2009,
Hope For Fibroids Inc.
(web site designed & developed by